Press Release: Ethicor Pharma : Phrixus Pharmaceuticals Announces European Access Program for Carmeseal-MD (P-188 NF) for Patients With Duchenne Muscular Dystrophy
Ethicor to Distribute Carmeseal-MD(TM) (P-188 NF) in Europe for the Treatment of Respiratory and Cardiac Dysfunction in Duchenne Muscular Dystrophy (DMD)...
Read full article »
Ethicor Pharma is focused on the development and distribution of unlicensed medicinal products.
Read more